New Key Statistics Module, Z-Score and F-Score
NAS:PSTX Key Ratios
| Market Cap $ M | 907.41 |
| Enterprise Value $ M | 759.29 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 10.40 |
| Price/Sales | 6.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 150.00 |
| EPS (TTM) $ | -0.62 |
| Beneish M-Score | -1.88 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 9.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -14.70 |
| EV-to-EBITDA | -16.45 |
| PEG | -- |
| Shares Outstanding M | 97.47 |
| Net Margin (%) | -40.28 |
| Operating Margin % | -41.43 |
| Pre-tax Margin (%) | -40.25 |
| Quick Ratio | 3.20 |
| Current Ratio | 3.20 |
| ROA % (ttm) | -21.23 |
| ROE % (ttm) | -66.04 |
| ROIC % (ttm) | -61.75 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.27 |
PSTX Number of Guru Trades
PSTX Volume of Guru Trades
Gurus Latest Trades with NAS:PSTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:PSTX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Poseida Therapeutics Inc Insider Transactions
No Available Data
News about NAS:PSTX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers